bay-k-8644 and D-fructopyranose

bay-k-8644 has been researched along with D-fructopyranose in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Richey, JM; Si, X; Webb, RC	1

Other Studies

1 other study(ies) available for bay-k-8644 and D-fructopyranose

Article	Year
Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats. Canadian journal of physiology and pharmacology, 1999, Volume: 77, Issue:10 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Bezafibrate; Blood Pressure; Body Weight; Calcium Channel Agonists; Dose-Response Relationship, Drug; Fructose; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; In Vitro Techniques; Lipoproteins, VLDL; Male; Rats; Rats, Sprague-Dawley; Vasoconstriction	1999

Article

Year

Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats.

Canadian journal of physiology and pharmacology, 1999, Volume: 77, Issue:10

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Bezafibrate; Blood Pressure; Body Weight; Calcium Channel Agonists; Dose-Response Relationship, Drug; Fructose; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; In Vitro Techniques; Lipoproteins, VLDL; Male; Rats; Rats, Sprague-Dawley; Vasoconstriction

1999